Zymeworks, Inc. (ZYME)
24.80
-0.43
(-1.70%)
USD |
NASDAQ |
Mar 05, 16:00
24.83
+0.03
(+0.12%)
After-Hours: 20:00
Zymeworks Free Cash Flow : -35.43M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Vertex Pharmaceuticals, Inc. | 3.194B |
| Krystal Biotech, Inc. | 188.91M |
| Scholar Rock Holding Corp. | -300.64M |
| Stoke Therapeutics, Inc. | 52.37M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.982M |
| Cash from Investing (Quarterly) | 5.10M |
| Cash from Financing (Quarterly) | -18.78M |
| Free Cash Flow Per Share (Quarterly) | -0.1418 |
| Free Cash Flow to Equity (Quarterly) | -10.05M |
| Free Cash Flow to Firm (Quarterly) | -10.68M |
| Free Cash Flow Yield | -1.88% |